Phillips TJ. Reply to: Glofitamab for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma. J Clin Oncol 2025 Feb 14:JCO2500088. doi: 10.1200/JCO-25-00088.
PMID: 39951674